$163.84 -0.14 (%) Amgen Inc - NASDAQ

May. 21, 2015 | 04:00 PM

Partner Headlines

  1. Health Care Sector Delivers Healthy Q1 Results

    IBD | May. 15, 2015 | 18:13PM EST
  2. IPO Stock Watch: Alder Soars On Migraine Drug Results

    IBD | May. 15, 2015 | 16:31PM EST
  3. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | May. 15, 2015 | 07:15AM EST
  4. The Best And Worst ETFs Of The Week Amid Biotech Rebound

    Benzinga | May. 9, 2015 | 10:49AM EST
  5. Regeneron Q1 Earnings Beat As Eylea Research Pays Off

    IBD | May. 7, 2015 | 11:22AM EST
  6. Crouching Tigers, Hidden Assets - Smead Capital Management

    GuruFocus | Apr. 30, 2015 | 18:19PM EST
  7. Amgen's Decline Could Be A Good Thing

    Benzinga | Apr. 29, 2015 | 12:42PM EST
  8. Should Amgen's T-Vec Results Be Questioned?

    Benzinga | Apr. 28, 2015 | 16:35PM EST
  9. Amgen drug misses fast track

    IBD | Apr. 27, 2015 | 18:45PM EST
  10. Why Baird Is Upgrading DaVita Healthcare

    Benzinga | Apr. 27, 2015 | 14:46PM EST
  11. Biotechs Weigh On Nasdaq, But Apple, Twitter Hold Firm

    IBD | Apr. 27, 2015 | 13:16PM EST
  12. Amgen Reports An Upbeat Q1 Earnings

    GuruFocus | Apr. 23, 2015 | 11:36AM EST
  13. Stocks Strengthen; Tesla Motors Rises On Battery News

    IBD | Apr. 22, 2015 | 15:04PM EST
  14. Stocks Mildly Higher; China Nods To Visa, MasterCard

    IBD | Apr. 22, 2015 | 11:53AM EST
  15. Amgen, Illumina Crush Views

    IBD | Apr. 21, 2015 | 18:51PM EST
  16. Amgen, Illumina Earnings Hot, Intuitive Surgical Not

    IBD | Apr. 21, 2015 | 18:00PM EST
  17. Amgen Tops Q1 Expectations, Shares Gain

    Benzinga | Apr. 21, 2015 | 17:12PM EST
  18. Strategist: Amgen To Move 3% On Q1 Earnings News

    Benzinga | Apr. 21, 2015 | 15:13PM EST
  19. What The Street...And The Crowd Are Watching At Amgen Before Earnings

    Benzinga | Apr. 21, 2015 | 14:04PM EST
  20. Amgen Inc.'s First Quarter Earnings Preview - What Could Be In Store?

    GuruFocus | Apr. 20, 2015 | 13:41PM EST
  21. 5 Biotech Earnings Under The Microscope This Week

    Benzinga | Apr. 20, 2015 | 11:18AM EST
  22. Amgen's First Drug For Cardiovascular Disease Gets The Green Light

    GuruFocus | Apr. 17, 2015 | 22:41PM EST
  23. Why Amgen Might Start To Turn Around

    Benzinga | Apr. 17, 2015 | 12:51PM EST
  24. Amgen Has A Big Launch Coming Up

    Benzinga | Apr. 16, 2015 | 16:04PM EST
  25. AMGEN

    IBD | Apr. 15, 2015 | 18:37PM EST
  26. AbbVie Upgraded On $7.8 Billion Imbruvica Potential

    IBD | Apr. 13, 2015 | 11:19AM EST
  27. Short Sellers Come Back To Biotech Stocks

    Benzinga | Feb. 26, 2015 | 13:25PM EST
  28. Making Money With Charles Payne: 02/25/15

    FoxBusiness | Feb. 25, 2015 | 18:00PM EST
  29. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  30. A Look At Dan Loeb's Diversified 13F

    Benzinga | Feb. 18, 2015 | 18:04PM EST
  31. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  32. Short Sellers Retreat From Biotech Stocks

    Benzinga | Feb. 12, 2015 | 08:23AM EST
  33. FDA Advisory Committee To Review Amgen's Talimogene Laherparepvec

    Benzinga | Feb. 11, 2015 | 16:23PM EST
  34. Dan Loeb Offers Mea Culpa For 'Mediocre' Returns

    Benzinga | Feb. 10, 2015 | 12:37PM EST
  35. Dan Loeb Fourth Quarter Investor Letter

    GuruFocus | Feb. 10, 2015 | 10:55AM EST
  36. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  37. Generic-Drug Makers Soar, And It's Easy To See Why

    IBD | Feb. 5, 2015 | 17:33PM EST
  38. Pfizer Buying Hospira To Inject Growth Into Generics

    IBD | Feb. 5, 2015 | 17:27PM EST
  39. Nuveen's Bob Doll Runs Several Top Funds

    IBD | Feb. 3, 2015 | 18:22PM EST
  40. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD | Jan. 28, 2015 | 15:35PM EST
  41. Credit Suisse Sees Solid Q4 For Amgen

    Benzinga | Jan. 28, 2015 | 09:14AM EST
  42. Amgen Q4 earnings top views

    IBD | Jan. 27, 2015 | 18:37PM EST
  43. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  44. Making Money With Charles Payne: 01/27/15

    FoxBusiness | Jan. 27, 2015 | 18:00PM EST
  45. Amgen Beats Q4 Expectations

    Benzinga | Jan. 27, 2015 | 17:20PM EST
  46. Stocks Weaken Late; Apple Jumps After Hours

    IBD | Jan. 27, 2015 | 17:12PM EST
  47. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  48. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga | Jan. 26, 2015 | 14:34PM EST
  49. Can CAR-T Therapy Live Up To The Biotech IPO Hype?

    IBD | Jan. 26, 2015 | 08:02AM EST
  50. New Guru Jana Partners' Newest Stock Buys

    GuruFocus | Jan. 22, 2015 | 21:05PM EST
Trading Center